Published in J Ultrasound on April 16, 2007
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol (2004) 3.56
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol (2003) 2.35
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol (2003) 1.74
Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther (2004) 1.72
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver Transpl (2005) 1.68
Natural history of recurrent hepatitis C. Liver Transpl (2002) 1.49
US of liver transplants: normal and abnormal. Radiographics (2003) 1.27
Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl (2003) 1.19
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Hepatic vein stenosis after living donor liver transplantation: evaluation with Doppler US. Radiology (2003) 1.19
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl (2002) 1.08
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl (2005) 1.06
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01
Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation (2004) 0.99
Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatology (1999) 0.99
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size. Hepatology (2002) 0.95
Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology (1994) 0.92
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transplant Proc (2001) 0.89
The value of color Doppler ultrasonography in monitoring normal orthotopic liver transplantation and postoperative complications. Hepatobiliary Pancreat Dis Int (2003) 0.83
Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: low risk of HBV reactivation. Transplantation (2005) 0.83
Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation. Transplant Proc (2003) 0.83
Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation (2005) 0.82
Changes of duplex parameters and splenic size in liver transplant recipients during a long period of observation. World J Gastroenterol (2005) 0.80
Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Liver Transpl (2001) 0.79
Adefovir-lamivudine combination therapy and hepatitis B viral kinetics. J Hepatol (2005) 0.77
Acute liver rejection: accuracy and predictive values of doppler US measurements--initial experience. Radiology (2005) 0.76
Ecographic epidemiology of non-parasitic hepatic cysts. J Clin Ultrasound (1993) 1.41
Evidence of Toscana virus infections without central nervous system involvement: a serological study. Eur J Epidemiol (1997) 1.13
Toscana virus infections of the central nervous system in children: a report of 14 cases. J Pediatr (1998) 1.04
Focal splenic lesions: US findings. J Ultrasound (2013) 1.01
Ultrasound imaging in cystic echinococcosis. Proposal of a new sonographic classification. Acta Trop (1997) 0.99
Contrast enhanced ultrasonography (CEUS) in peripheral lung lesions: A study of 60 cases. J Ultrasound (2008) 0.98
Relapsing fever in a traveller from Senegal: determination of Borrelia species using molecular methods. Trans R Soc Trop Med Hyg (2006) 0.90
Black aspergilli and ochratoxin A in grapes in Italy. Int J Food Microbiol (2006) 0.88
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania. HIV Med (2008) 0.87
Pseudoaneurysm of the hepatic artery, a rare complication of an amebic liver abscess. J Ultrasound (2009) 0.81
Thrombocytopenia in patients with HCV-positive chronic hepatitis: efficacy of leucocyte interferon-alpha treatment. Int J Clin Pract (2003) 0.80
One hundred sixteen cases of acute liver failure treated with MARS. Transplant Proc (2005) 0.79
Sonographic management of complicated cystic echinococcosis. J Ultrasound (2007) 0.77
Prevalence and chemosusceptibility of Neisseria meningitidis and Haemophilus influenzae in a population of central Italy. New Microbiol (2003) 0.77
Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors. J Vet Intern Med (2015) 0.75
Sonographic management of mediastinal syndrome. J Ultrasound (2009) 0.75
Cutaneous leishmaniasis: usefulness of PCR on paraffin-embedded skin biopsies as part of routine investigation. Ann Trop Med Parasitol (2007) 0.75
[Monitoring of conjunctival PO2 during general anesthesia for eye surgery]. Minerva Anestesiol (1986) 0.75
Oxygen tension monitoring in uremic patients during hemodialysis treatment. Artif Organs (1990) 0.75
Pregnancy in a patient with essential thrombocytosis. Clin Exp Obstet Gynecol (1997) 0.75
Human leishmaniasis in Tuscany: a changing pattern of visceral disease? Ann Trop Med Parasitol (2010) 0.75
[Appendicitis: microbial interactions and new pathogens]. Recenti Prog Med (1992) 0.75
[Schizophrenia and language disorders]. Encephale (1994) 0.75
[Clinical evaluation of the efficacy of Ro 15-1788, Anexate after balanced intravenous anesthesia with flunitrazepam and fentanyl]. Minerva Anestesiol (1989) 0.75